MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery Aug. 13, 2018 No Comments
BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group July 30, 2018 No Comments
Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides May 8, 2018 No Comments
RSS